Background/aim: Oligometastatic disease for nonsmall cell lung cancer (NSCLC) patients is
generally thought to represent a better prognosis with a quieter biology, limited number of …

Bronchogenic carcinoma is the leading cause of death due to cancer worldwide. Nearly
75% of patients have a disseminated carcinoma at diagnosis. Up to 50% of patients with a …

El carcinoma broncogénico es la causa más frecuente de muerte por cáncer en el mundo.
Cerca del 75% de los pacientes presentan enfermedad diseminada en el momento del …

© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2020; 12 (4): 1612-1614|
http://dx. doi. org/10.21037/jtd. 2020.03. 32 38.8 months, median PFS was 14.2 months in …

Metachronous oligo-metastatic disease is variably defined as one to five metastases
detected after a disease-free interval and treatment of the primary tumour with curative …

Despite an overall decrease in tobacco use, lung cancer (80–85% of which is non-small-cell
lung cancer [NSCLC]) is still the leading cause of cancer death in both men and women …

Simple Summary Many patients with metachronous oligo-metastases in non-small cell lung
cancer have their recurrences surgically removed, although the 5-year recurrence-free …

Metachronous oligo-metastatic disease is variably defined as one to five metastases
detected after a disease-free interval and treatment of the primary tumour with curative …